An FDA decision date is the closest thing the options market has to a coin flip with a calendar invite. The date is public, the outcome is mostly yes or no, and the option prices around it reflect that. Most of the money lost on these trades is lost by people who guessed the direction correctly and still came out behind, or who sized the position as if it were an ordinary trade.
Key Takeaways
- A PDUFA date is an FDA goal date for a decision on a drug application, not a guaranteed event time. Decisions can arrive early, late, or be extended.
- Implied volatility rises into the event and collapses after it. A long option can lose money even when you are right on direction if the move is smaller than the options priced in.
- The straddle price tells you the move the market expects. Compare any trade idea to that number before anything else.
- Defined-risk structures and small position size matter more here than in almost any other setup, because the stock can gap past any stop.
- For many retail traders, watching these events teaches more than trading them.
What a PDUFA date actually is
PDUFA stands for the Prescription Drug User Fee Act. Under it, the FDA commits to review goals for new drug applications. The PDUFA date (also called the goal date) is the target by which the agency aims to finish its review and act. Under the standard review track the goal is generally ten months from the point the application is accepted for filing, and under priority review it is generally six months.
Three details matter for traders:
- It is a goal, not a hard deadline. The FDA can miss it, and a major amendment to the application can extend the review clock by several months.
- The outcome is not simply approve or reject. The agency can approve, approve with a narrower label than the company wanted, or issue a complete response letter (CRL) that lists what must be fixed before approval. Each produces a different price reaction.
- The news often arrives outside regular hours. Companies commonly announce decisions after the close or before the open, so the gap happens while your position cannot be traded.
Dates come from company press releases, quarterly filings and investor presentations. Treat any third-party calendar as a convenience and confirm against the company’s own disclosure before building a position around a specific day.
Why options get so expensive before the event
Market makers price options by estimating how far a stock might move. On an ordinary day for an ordinary stock that estimate is a smooth distribution. Before a binary event it is closer to two clusters: one where the drug is approved and one where it is not. No hedge can smooth that out, because the stock does not trade through the middle. It jumps.
The result is implied volatility that is often far above the stock’s normal level, concentrated in the expiration that spans the decision. Once the news is out, the uncertainty disappears and implied volatility drops sharply, which is the same mechanism covered in our earnings options strategies guide and the IV crush case study. The difference is size and shape. Earnings moves are usually a matter of degrees; a regulatory decision on a single-product company can be a matter of whether the business has a future.
Step one: read the implied move
The at-the-money straddle (one call plus one put at the same strike) is a quick estimate of the move the market expects. Divide its price by the stock price.
| Illustrative input | Value |
|---|---|
| Hypothetical stock price | $20.00 |
| At-the-money call, expiration after the PDUFA date | $3.20 |
| At-the-money put, same expiration | $2.80 |
| Straddle cost | $6.00 |
| Implied move ($6.00 / $20.00) | about 30% |
These numbers are hypothetical and exist only to show the arithmetic. In this example, a long call buyer needs the stock to rise well past the strike plus the premium paid to profit at expiration, and a modest approval pop of, say, 15% could still leave a long call or a long straddle in the red. That is the central trap: the market has already priced in a big move, so you need a bigger one.
Step two: decide what you are actually betting on
Before choosing a structure, write down which of these you believe, because each calls for a different trade:
- The decision will be favorable and the stock will move more than implied. This is a directional view with a size requirement, which is hard to be right about.
- The move will be smaller than implied. This is a view on volatility, and it suggests selling premium, but only in defined-risk form.
- I have no edge on the outcome. This is the honest answer for most people, and it points to staying out.
Structures that fit, and one that does not
| Structure | Max loss | What it needs | Main problem |
|---|---|---|---|
| Long call or long put | Premium paid | Correct direction and a move larger than the premium | Volatility drop after the event erodes value even on a correct call |
| Long straddle | Total premium | A move larger than the implied move in either direction | Very expensive going in; a typical outcome is a loss |
| Vertical debit spread | Net debit | Correct direction, moderate move | Caps the upside on exactly the outcome that pays most |
| Iron condor or wide short strangle | Defined for the condor; very large to unlimited for the naked strangle | A move smaller than implied | A gap through the short strikes produces a maximum loss, and the naked version can exceed the account |
The structure to avoid is any naked short option held through the event. A stock can gap far past where a stop order would trigger, and the fill comes at the post-gap price, not your stop. If you want to sell premium, a defined-risk spread turns an open-ended loss into a known one. Our guide to the short straddle explains why the naked version is dangerous even without a binary event.
Position size is the real strategy
On a binary event you should assume the full amount at risk can be lost, because it often is. A workable rule is to decide the largest loss you can take without it changing your week, and size the position so that a total loss on it equals that figure. Many traders cap a single binary-event position at one percent of the account or less. Our options position sizing guide walks through the calculation.
Two practical points on execution:
- Check liquidity before the idea. Small-cap biotech options frequently have wide bid-ask spreads and thin open interest. A spread of 20 cents on a $1.00 option is a 20% cost before the stock moves. Use limit orders and look at the bid-ask, not the last trade.
- Know your costs. Multi-leg structures multiply per-contract fees. For example, tastytrade lists $1.00 per contract to open and $0 to close, capped at $10 per leg (verified 2026-10-03), so a four-leg condor can cost noticeably more in commissions than a single long call. Check your own broker’s current schedule.
Large companies versus single-product companies
A large pharmaceutical company with dozens of products moves modestly on one decision, because that decision is a small share of its value. A small company with one lead drug can move by a large fraction of its market value in a single session. The options market reflects this: implied moves are small for the first group and enormous for the second. Strategy selection should follow. Something that is reasonable on a diversified company can be reckless on a single-product one, so match your size to the company, not to the tidy look of the chart.
The run-up question
Some traders buy ahead of a decision and sell before it, aiming to capture the rise in implied volatility and any speculative buying without holding through the binary outcome. This can work, but there is no guarantee that the run-up occurs, and it can reverse on a delay, a negative advisory committee vote or a broad market sell-off. If you try it, treat the exit date as a rule written in advance, not a decision to make in the moment.
Bottom Line
The market prices FDA decisions aggressively, so being right on direction is not enough; you must also beat the implied move. Use defined-risk structures, size the position as a total loss, and be willing to pass. For most retail traders, studying how these events resolve is a better use of time than trading them.
Frequently Asked Questions
Q: What does PDUFA stand for?
A: The Prescription Drug User Fee Act. It sets review-time goals for the FDA, and the PDUFA date is the goal date for a decision on an application.
Q: Is the FDA required to decide on the PDUFA date?
A: No. It is a performance goal. Decisions can come early, can slip, and the review can be extended if the company submits a major amendment.
Q: Why did my call option lose money after good news?
A: Usually because implied volatility fell sharply once the event passed, and the stock’s move was smaller than what the option price had already assumed.
Q: Can I sell options into a PDUFA date to collect the high premium?
A: Only with defined risk, if at all. A naked short option can lose many times the premium collected if the stock gaps. A spread or condor limits the loss to a known amount.
Q: Where do I find PDUFA dates?
A: Start with the company’s own press releases and filings, which are the primary source, and confirm any date you see on a third-party calendar against them.
Keep learning
Binary events are one kind of volatility trade. Our guide to implied volatility covers why option prices inflate and deflate, and the earnings options strategies guide shows the more common version of the same pattern.